← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 23, 2017Last known activity
Jan 28, 2025
Timeline
2010s
- Jun 1, 2017
KeyBioscience AG— Founded
Drugs by trial phase (3 distinct, 3 trials)
Indications
Studied for
Recent trials (3)
- NCT06833749Lead sponsorPhase 2Jan 28, 2025
- NCT03907202Lead sponsorPhase 1Apr 17, 2018
- NCT03230786Lead sponsorPhase 2Aug 23, 2017
Details
- Founded
- Nidwalden, CH Jun 1, 2017
- Last known activity
- Jan 28, 2025